Table 1.
Patients’ characteristics
| Characteristic | Patients (N = 30) | |
|---|---|---|
| n | % | |
| Median age, y (range) | 29 (21-77) | |
| Age 45-60 | 4 | 13.3 |
| Age >60 | 4 (67-77) | 13.3 |
| Sex | ||
| Male | 11 | 36.7 |
| Female | 19 | 63.3 |
| Disease stage | ||
| IIA | 6 | 20.0 |
| IIB | 6 | 20.0 |
| IIB with >10 cm mass | 5 | 16.7 |
| IIIA | 4 | 13.3 |
| IIIB | 1 | 3.3 |
| IVA | 6 | 20.0 |
| IVB | 7 | 23.3 |
| IPS Score* | ||
| 0-1 | 4 | 13.3 |
| 2 | 6 | 20.0 |
| 3 | 6 | 20.0 |
| ≥4 | 2 | 6.7 |
| ESR >50† | 6 | 50 |
| B symptoms | 14 | 46.7 |
| Extranodal disease | 16 | 53.3 |
| Bone‡ | 14 | 46.7 |
| Lung‡ | 3 | 10.0 |
| Bulky | ||
| >7 cm† | 11 | 91.7 |
| >10 cm | 10 | 33.3 |
| MMR >1/3 | 9 | 30.0 |
| >10 cm or MMR >1/3 | 12 | 40.0 |
IPS, International Prognostic Score; ESR, erythrocyte sedimentation rate, MMR, maximum mediastinal ratio.
*
Advanced stage patients only (n = 18).
†
Early-stage patients only (n = 12).
‡
Direct extension to bone in 2 cases (stages IIAE and IIIAE) and to lung in 1 case (stage IIBE).